Phone:| Tech Support:| E-mail:
Home > Products > Small molecule > DNA Damage > Levofloxacin

Levofloxacin

Product #: TL0034
Image SKU-Pack Size Stock Price($) Quantity

Documents

Details

l  General Information

Product Name

Levofloxacin

General description

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to  blockage of bacterial cell growth.

Synonym

(−)-Ofloxacin;Levaquin; Quixin; Iquix; Levofloxacine;

Purity

≥98%(HPLC)

CAS Number

100986-85-4

Formula

C18H20FN3O4

Molecular Weight

361.37

Suitability

BioReagent, suitable for cell culture, etc.

l  Physical and Chemical Information

Appearance

White to pale yellow solid

Solubility(25℃)

DMSO

≥20mg/mL

Ethanol

~10mg/mL

Water

~10mg/mL

l  Biological Information

Biochem/Physiol   Actions

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. Levofloxacin diffuses through the bacterial cell wall and acts by inhibiting DNA gyrase (bacterial topoisomerase II), an enzyme required for DNA replication, RNA transcription, and repair of bacterial DNA. Inhibition of DNA gyrase activity leads to blockage of bacterial cell growth.

Application

1.      Cytochrome P-450 CYP1A2 Inhibitors

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP1A2.

2.    Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA.

3.    Topoisomerase II Inhibitors

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II.

4.    Anti-Infective Agents, Urinary

Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.

l  Packaging & Storage

Packaging

1g

Storage temp.

0-5℃

l  Precautions and Disclaimer

This   product is for R&D use only, not for drug, household, or other uses.

l  References

1.    http://www.drugbank.ca

2.    https://ncit.nci.nih.gov

3.    https://www.ncbi.nlm.nih.gov

 


天问科技